scispace - formally typeset
J

Jan Reedijk

Researcher at Leiden University

Publications -  1165
Citations -  45902

Jan Reedijk is an academic researcher from Leiden University. The author has contributed to research in topics: Ligand & Crystal structure. The author has an hindex of 80, co-authored 1163 publications receiving 43747 citations. Previous affiliations of Jan Reedijk include Nagoya City University & University of Münster.

Papers
More filters
Journal ArticleDOI

Spectroscopic and magnetic properties of a new class of two-dimensional bitriazole compounds: The X-ray structure of poly-bis(thiocyanato-N)-bis-μ-(4,4′-bis-1,2,4-triazole-N1,N1′)-cobalt(II) monohydrate

TL;DR: In this paper, the synthesis of two-dimensional triazole compounds is described, including the crystal structure of [Co(NCS)2(btr)2]H2O [btr stands for 4,4′-bis-1,2,4-triazole (C4H4N6)].
Journal ArticleDOI

A Na2WO4/H2WO4-Based Highly Efficient Biphasic Catalyst towards Alkene Epoxidation, using Dihydrogen Peroxide as Oxidant

TL;DR: The tungsten-containing biphasic catalytic system [Na 2 WO 4 /H 2WO 4 PTR/chloroacetic acid] effectively epoxidizes alkenes with 50% H 2 O 2 as terminal oxidant, under organic solvent-free conditions.
Journal ArticleDOI

Synthesis and catalytic activities of copper(II) complexes derived from a tridentate pyrazole-containing ligand. X-ray crystal structure of [Cu2(μ-dpzhp-O,N,N′)2][Cu(MeOH)Cl3]2

TL;DR: In this paper, the synthesis of the tridentate ligand 1,3-bis(3,5-dimethylpyrazol-1-yl)propan-2-ol (Hdpzhp) and a number of its copper(II) complexes are described.
Journal ArticleDOI

Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.

TL;DR: Three new asymmetric platinum(II) complexes comprising an isopropylamine ligand trans to an azole ligand were synthesized and fully characterized by (1)H NMR, (195)Pt N MR, IR and elemental analysis, illustrating how platinum complexes of trans geometry can show improved activity compared to cis Platin in both cisplatin sensitive and cisplats resistant cell lines.